Similar articles for PMID: 29287771

Year	Number of Results
1943	1
1973	1
1977	1
1979	1
1981	1
1983	1
1986	1
1993	1
1996	1
1999	1
2000	1
2001	3
2002	1
2003	2
2004	2
2005	3
2006	1
2007	3
2008	2
2009	5
2010	1
2011	2
2012	4
2013	7
2014	9
2015	9
2016	8
2017	12
2018	15
2019	6
2020	2
2021	1
2022	1
2024	0

1

Lower antibody functionality in middle-aged adults compared to adolescents after primary meningococcal vaccination: Role of IgM.

van der Heiden M, van Ravenhorst MB, Bogaard M, Boots AMH, Berbers GAM, Buisman AM. van der Heiden M, et al. Exp Gerontol. 2018 May;105:101-108. doi: 10.1016/j.exger.2017.12.014. Epub 2017 Dec 26. Exp Gerontol. 2018. PMID: 29287771 Free article. Clinical Trial.

2

Adolescent meningococcal serogroup A, W and Y immune responses following immunization with quadrivalent meningococcal A, C, W and Y conjugate vaccine: Optimal age for vaccination.

van Ravenhorst MB, van der Klis FRM, van Rooijen DM, Sanders EAM, Berbers GAM. van Ravenhorst MB, et al. Vaccine. 2017 Aug 24;35(36):4753-4760. doi: 10.1016/j.vaccine.2017.06.007. Epub 2017 Jun 21. Vaccine. 2017. PMID: 28647167 Clinical Trial.

3

Long-term immunogenicity and safety after a single dose of the quadrivalent meningococcal serogroups A, C, W, and Y tetanus toxoid conjugate vaccine in adolescents and adults: 5-year follow-up of an open, randomized trial.

Borja-Tabora CF, Montalban C, Memish ZA, Boutriau D, Kolhe D, Miller JM, Van der Wielen M. Borja-Tabora CF, et al. BMC Infect Dis. 2015 Oct 6;15:409. doi: 10.1186/s12879-015-1138-y. BMC Infect Dis. 2015. PMID: 26437712 Free PMC article. Clinical Trial.

4

Novel Intervention in the Aging Population: A Primary Meningococcal Vaccine Inducing Protective IgM Responses in Middle-Aged Adults.

van der Heiden M, Boots AMH, Bonacic Marinovic AA, de Rond LGH, van Maurik M, Tcherniaeva I, Berbers GAM, Buisman AM. van der Heiden M, et al. Front Immunol. 2017 Jul 19;8:817. doi: 10.3389/fimmu.2017.00817. eCollection 2017. Front Immunol. 2017. PMID: 28769927 Free PMC article.

5

Meningococcal serogroup C immunogenicity, antibody persistence and memory B-cells induced by the monovalent meningococcal serogroup C versus quadrivalent meningococcal serogroup ACWY conjugate booster vaccine: A randomized controlled trial.

van Ravenhorst MB, van der Klis FRM, van Rooijen DM, Knol MJ, Stoof SP, Sanders EAM, Berbers GAM. van Ravenhorst MB, et al. Vaccine. 2017 Aug 24;35(36):4745-4752. doi: 10.1016/j.vaccine.2017.06.053. Epub 2017 Jun 28. Vaccine. 2017. PMID: 28668575 Clinical Trial.

6

Use of saliva to monitor meningococcal vaccine responses: proposing a threshold in saliva as surrogate of protection.

van Ravenhorst MB, van der Klis FRM, van Rooijen DM, Sanders EAM, Berbers GAM. van Ravenhorst MB, et al. BMC Med Res Methodol. 2019 Jan 5;19(1):1. doi: 10.1186/s12874-018-0650-3. BMC Med Res Methodol. 2019. PMID: 30611213 Free PMC article.

7

Long-term persistence of protective antibodies in Dutch adolescents following a meningococcal serogroup C tetanus booster vaccination.

van Ravenhorst MB, Marinovic AB, van der Klis FR, van Rooijen DM, van Maurik M, Stoof SP, Sanders EA, Berbers GA. van Ravenhorst MB, et al. Vaccine. 2016 Dec 7;34(50):6309-6315. doi: 10.1016/j.vaccine.2016.10.049. Epub 2016 Nov 4. Vaccine. 2016. PMID: 27817957

8

Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine.

Robertson CA, Greenberg DP, Hedrick J, Pichichero M, Decker MD, Saunders M. Robertson CA, et al. Vaccine. 2016 Oct 17;34(44):5273-5278. doi: 10.1016/j.vaccine.2016.09.003. Epub 2016 Sep 15. Vaccine. 2016. PMID: 27642132 Free article. Clinical Trial.

9

Antibody persistence in Australian adolescents following meningococcal C conjugate vaccination.

Perrett KP, Richmond PC, Borrow R, Nolan T, McVernon J. Perrett KP, et al. Pediatr Infect Dis J. 2015 Mar;34(3):279-85. doi: 10.1097/INF.0000000000000541. Pediatr Infect Dis J. 2015. PMID: 25742078 Free article.

10

Persistence of the immune response two years after vaccination with quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) in Asian adolescents.

Quiambao BP, Jain H, Bavdekar A, Dubey AP, Kolhe D, Bianco V, Van der Wielen M, Miller JM. Quiambao BP, et al. Hum Vaccin Immunother. 2016 Aug 2;12(8):2162-2168. doi: 10.1080/21645515.2016.1163455. Epub 2016 May 6. Hum Vaccin Immunother. 2016. PMID: 27152501 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

103 results

Results by year